SEC filing record
Primary Source · SEC.gov

Centaur Health Holdings, Inc.

2026 vintageRule 506(b)Filing record

Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.

Latest signalSold increasedForm D/A · 2026-08-2115 events: 3 sold increased, 3 offering upsized, 3 investors increasedLast filing 2026-08-21

Raised

$50M

Investors

35

Min Invest

$25,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

What this filing shows

·

Every sentence is a value as filed on SEC Form D

Centaur Health Holdings, Inc. is a Delaware corporation that first filed a Form D on November 3, 2016 and most recently amended it on August 21, 2026 in the Other Health Care industry group. The offering claims Rule 506(b) and covers equity. Centaur Health Holdings, Inc. reported $50,399,997 sold from 35 investors of a $56,999,962 total offering as of the Form D filed August 21, 2026. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $25,000. The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. The issuer's address of record is 7921 Uw Health Ct., Middleton, WI 53562.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001688486
Entity NameCentaur Health Holdings, Inc.
ExemptionRule 506(b)
What the exemption meansRule 506(b) of Regulation D: securities may be sold to an unlimited number of accredited investors and up to 35 non-accredited investors who meet the rule's sophistication standard, without general solicitation or advertising.
Entity TypeCorporation
Jurisdiction of OrganizationDelaware
Issuer Address7921 Uw Health Ct., Middleton, WI 53562
Phone(608) 286-0881
Former NamesAsto CT, Inc (until August 12, 2020); Asto CT, LLC (until September 28, 2018)
Industry / Fund TypeOther Health Care
Securities TypeEquity
First Sale DateApril 3, 2026
Filing DateAugust 21, 2026
Accession Number0001688486-26-000002
Total Offering Amount$56,999,962
Total Amount Sold$50,399,997
Amount Remaining$6,599,965
Total Investors35
Non-Accredited InvestorsNone
Minimum Investment$25,000
Offering DurationOne year or less
Revenue RangeDecline to Disclose
State (Issuer Address)WI
Amendment Count12 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

15

latest Aug 21, 2026

Critical / warning

0 / 0

9 watch · 6 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

7

dark, lapsed, closed, pre_sale, raising

Latest event Sold increase · Aug 21, 2026

SEC.gov
Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Investor

  • 15 filing events with values and deltas, latest 2026-08-21, and alerts on the next one
  • 7 offering timelines: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Thomas R. Mackie

Executive Officer, Director, Promoter · Middleton, WI

David Ergun

Executive Officer, Director, Promoter · Middleton, WI

Stephen Towe

Executive Officer, Director · West Sussex, X0

Dennis Beard

Director · Champaign, IL

Ajit Singh

Director · Palo Alto, CA

Mark Wang

Director · Singapore, U0

Pingrong Yu

Director · Palo Alto, CA

Gregory Lane

Director · Grand Blanc, MI

Andy Harley

Executive Officer · West Sussex, X0

Questions About Centaur Health Holdings, Inc.

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is Centaur Health Holdings, Inc.?

Centaur Health Holdings, Inc. is a Delaware corporation that filed a Form D with the SEC on August 21, 2026 in the Other Health Care industry group. The filing claims Rule 506(b) for an offering of equity.

Is Centaur Health Holdings, Inc. legit?

AltStreet does not rate legitimacy; it reports the public record. Centaur Health Holdings, Inc. filed a Form D with the SEC on August 21, 2026 claiming Rule 506(b). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $50,399,997 sold to 35 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is Centaur Health Holdings, Inc. registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that Centaur Health Holdings, Inc. claimed Rule 506(b) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has Centaur Health Holdings, Inc. raised?

Centaur Health Holdings, Inc. reported $50,399,997 sold from 35 investors of a $56,999,962 total offering as of the Form D filed August 21, 2026.

Who can invest in Centaur Health Holdings, Inc.?

The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $25,000.

What is the minimum investment in Centaur Health Holdings, Inc.?

The Form D lists $25,000 as the minimum investment accepted from any outside investor as of August 21, 2026. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling Centaur Health Holdings, Inc. and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly.

Who is behind Centaur Health Holdings, Inc.?

The Form D lists 9 related persons: Thomas R. Mackie, executive officer, director, promoter; David Ergun, executive officer, director, promoter; Stephen Towe, executive officer, director; Dennis Beard, director; Ajit Singh, director; Mark Wang, director; Pingrong Yu, director; Gregory Lane, director, and 1 more. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is Centaur Health Holdings, Inc. located?

The issuer's address on its SEC filings is 7921 Uw Health Ct., Middleton, WI 53562. Its phone number of record is 608-286-0881. It is organized under the laws of Delaware.

How long is the Centaur Health Holdings, Inc. offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 5 amendments are on record for this CIK.

What is Centaur Health Holdings, Inc.'s revenue?

The issuer declined to disclose its revenue range on the Form D, which the form permits.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.